Cytokines in the Control of Beta-2 Microglobulin Release. II. In vivo Studies with Recombinant Interferons and Antigens
✍ Scribed by Nachbaur, K.; Troppmair, J.; Kotlan, B.; König, P.; Aulitzky, W.; Bieling, P.; Huber, C.H.
- Book ID
- 123289501
- Publisher
- Elsevier Science
- Year
- 1988
- Tongue
- English
- Weight
- 451 KB
- Volume
- 177
- Category
- Article
- ISSN
- 0171-2985
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The immunogenicity and tolerogenicity of 2,4‐dinitrophenyl (DNP) conjugates of levan, type 3 pneumococcal polysaccharide (SIII), dextran B512 and dextran B 1299 with different levels of substitution were assessed __in vivo__. It was confirmed that, as __in vitro__, conjugates with low e
We have previously reported the production of a new monoclonal antibody (MAb) (SP-2) recognizing a 90-kDa tumorassociated antigen, termed 9OK. which is increased in the serum of many cancer patients. Treatment of CG5 human breast cancer cells with recombinant interferon-a 2b (rlFN-a 2b) can increase